Potential Genotoxicity of Alkaloids: A Review Article
DOI:
https://doi.org/10.55544/sjmars.4.5.2Keywords:
Alkaloids, Genotoxicity, DNA damage, Mutagenicity, Carcinogenicity, Natural products, ToxicologyAbstract
Any harm done to genetic material, whether directly interacting with DNA or indirectly through biological systems, is referred to as genotoxicity. Such harm poses major risks to the health of people, animals, and plants as it is a primary source of carcinogenesis, mutagenesis, and teratogenesis. Because of their medicinal qualities, alkaloids—a family of naturally occurring phytochemicals made by plants from amino acids—are frequently utilized to treat ailments such newborn apnea, gout, and asthma. Recent research has sparked worries about their possible genotoxic consequences despite their therapeutic advantages. Through a variety of processes, including as the creation of DNA adducts, DNA–DNA cross-links, and DNA–protein cross-links, alkaloids have been demonstrated to cause chromosomal abnormalities. These processes can all impede DNA replication, transcription, and repair.
The aims to investigate and compile the most recent scientific findings about the genotoxic potential of alkaloids, emphasizing both the hazards of prolonged exposure and the molecular mechanisms of action. Along with highlighting the pervasive and frequently uncontrolled use of plant-based remedies under the false pretence of safety, it also seeks to distinguish genotoxicity from similar ideas like mutagenicity and teratogenicity.
In conclusion, alkaloids have significant therapeutic potential; however, care is advised due to their potential to harm genetic material. Standardized testing procedures like the Ames, comet, and micronucleus tests are necessary to provide a more thorough knowledge of their genotoxic processes. This knowledge is essential for risk assessment as well as for directing the safe use of treatments containing alkaloids in both conventional and clinical medicine.
References
[1] Phillips DH, Arlt VM. Genotoxicity: damage to DNA and its consequences. EXS. 2009; 99:87-110. doi: 10.1007/978-3-7643-8336-7_4.
[2] Ellinger-Ziegelbauer, H., Aubrecht, J., Kleinjans, J. C., and Ahr, H. J. (2009). Application of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity. Toxicol. Lett. 186, 36–44. doi:10.1016/j.toxlet.2008.08.017.
[3] Ren, N., Atyah, M., Chen, WY. et al. The various aspects of genetic and epigenetic toxicology: testing methods and clinical applications. J Transl Med 15, 110 (2017).
[4] Cristóbal-Luna JM, Paniagua-Castro N, Escalona-Cardoso GN, Pérez-Gutiérrez MS, Álvarez-González I, Madrigal-Bujaidar E, Chamorro-Cevallos G. Evaluation of teratogenicity and genotoxicity induced by kramecyne (KACY). Saudi Pharm J. 2018 Sep;26(6):829-838.
[5] Lázaro, D. C., López, Y. I., Vázquez, A. I. F., Odio, A. D., González, J. E., Sánchez, L. M., et al. (2010). Genotoxic assessment of aqueous extract of Rhizophora mangle L.(mangle rojo) by spermatozoa head assay. Rev. Cubana Plantas Med. 15, 18–26.
[6] Menz J, Götz ME, Gündel U, Gürtler R, Herrmann K, Hessel-Pras S, Kneuer C, Kolrep F, Nitzsche D, Pabel U, Sachse B, Schmeisser S, Schumacher DM, Schwerdtle T, Tralau T, Zellmer S, Schäfer B. Genotoxicity assessment: opportunities, challenges and perspectives for quantitative evaluations of dose-response data. Arch Toxicol. 2023 Sep;97(9):2303-2328.
[7] Donner EM, Wong BA, James RA, Preston RJ. Reciprocal translocations in somatic and germ cells of mice chronically exposed by inhalation to ethylene oxide: implications for risk assessment. Mutagenesis. 2010;25(1):49–55.
[8] Zeiger E. Historical perspective on the development of the genetic toxicity test battery in the United States. Environ Mol Mutagen. 2010;51(8–9):781–791.
[9] Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA. Environmental and chemical carcinogenesis. Semin Cancer Biol. 2004;14(6):473–486.
[10] Kirkland, D., Aardema, M., Henderson, L., and Müller, L. (2005). Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat. Res. 584, 1–256.
[11] Godlewska-Żyłkiewicz B, Świsłocka R, Kalinowska M, Golonko A, Świderski G, Arciszewska Ż, Nalewajko-Sieliwoniuk E, Naumowicz M, Lewandowski W. Biologically Active Compounds of Plants: Structure-Related Antioxidant, Microbiological and Cytotoxic Activity of Selected Carboxylic Acids. Materials (Basel). 2020 Oct 8;13(19):4454.
[12] Nedorostova L., Kloucek P., Kokoska L., Stolcova M., Pulkrabek J. Antimicrobial properties of selected essential oils in vapour phase against foodborne bacteria. Food Control. 2009;20:157–160.
[13] Mancini E., Camele I., Elshafie H.S., De Martino L., Pellegrino C., Grulova D., De Feo V. Chemical composition and biological activity of the essential oil of Origanum vulgare ssp. hirtum from different areas in the Southern Apennines (Italy) Chem. Biodivers. 2014;11:639–651.
[14] Nik Mohamad Nek Rahimi N., Natrah I., Loh J.-Y., Ervin Ranzil F.K., Gina M., Lim S.-H.E., Lai K.-S., Chong C.-M. Phytocompounds as an Alternative Antimicrobial Approach in Aquaculture. Antibiotics. 2022;11:469.
[15] Marchese A., Orhan I.E., Daglia M., Barbieri R., Di Lorenzo A., Nabavi S.F., Gortzi O., Izadi M., Nabavi S.M. Antibacterial and antifungal activities of thymol: A brief review of the literature. Food Chem. 2016;210:402–414.
[16] Liao W, Huang L, Han S, Hu D, Xu Y, Liu M, Yu Q, Huang S, Wei D, Li P. Review of Medicinal Plants and Active Pharmaceutical Ingredients against Aquatic Pathogenic Viruses. Viruses. 2022 Jun 13;14(6):1281.
[17] Muhammad, H., Gomes-Carneiro, M. R., Poça, K. S., De-Oliveira, A. C., Afzan, A., Sulaiman, S. A., et al. (2011). Evaluation of the genotoxicity of Orthosiphon stamineus aqueous extract. J. Ethnopharmacol. 133, 647–653.
[18] Al-Anizi, A. A., Hellyer, M. T., and Zhang, D. (2014). Toxicity assessment and modelling of Moringa oleifera seeds in water purification by whole cell bioreporter. Water Rese 56, 77–87.
[19] Hamilton, A. C. (2004). Medicinal plants, conservation and livelihoods. Biodivers. Conserv. 13, 1477–1517.
[20] Sponchiado, G., Adam,M. L., Silva, C. D., Soley, B. S., de Mello-Sampayo, C., Cabrini, D. A., et al. (2016). Quantitative genotoxicity assays for analysis of medicinal plants: a systematic review. J. Ethnopharmacol. 178, 289–296.
[21] Ping, K. Y., Shohaimi, S., Sasidharan, S., and Yusuf, U. K. (2017). Genotoxicity of selected Chinese medicinal plants, elephantopus scaber, Glycyrrhiza uralensis and salvia miltiorrhiza on Allium cepa assay. Ann. Pharmacol. Pharm. 2, 1070.
[22] Suzanne, J. P. L., Berg, V. D., Patrizia, R., Marelle, G. B., Delmulle, L., and Ivonne, M. C. M. R. (2011). Levels of genotoxic and carcinogenic compounds in plant food supplements and associated risk assessment. FNS 2, 989–1010.
[23] Akagi J, Toyoda T, Cho YM, et al. Validation study of the combined repeated-dose toxicity and genotoxicity assay using gpt delta rats. Cancer Sci. 2015;106(5):529–541.
[24] Verpoorte R. Encyclopedia of Analytical Science. Elsevier; Amsterdam, The Netherlands: 2005. ALKALOIDS; pp. 56–61
[25] Srivastava S., Srivastava A.K. Biotechnology and Genetic Engineering for Alkaloid Production. In: Ramawat K.G., Mérillon J.-M., editors. Natural Products: Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes. Springer; Berlin/Heidelberg, Germany: 2013. pp. 213–250.
[26] Jilani A., Legseir B., Soulimani R., Dicko A., Younos C. New extraction technique for alkaloids. J. Braz. Chem. Soc. 2006;17.
[27] Kaur R., Arora S. Alkaloids—Important Therapeutic Secondary Metabolites of Plant Origin. J. Crit. Rev. 2015;2:1–8.
[28] Chik S.C.C., Or T.C.T., Luo D., Yang C.L.H., Lau A.S.Y. Pharmacological Effects of Active Compounds on Neurodegenerative Disease with Gastrodia and Uncaria Decoction, a Commonly Used Poststroke Decoction. Sci. World J. 2013;2013:1–22. doi: 10.1155/2013/896873.
[29] Kurek J. Alkaloids—Their Importance in Nature and Human Life. IntechOpen; London, UK: 2019. Introductory Chapter: Alkaloids—Their Importance in Nature and for Human Life.
[30] Amirkia V., Heinrich M. Alkaloids as drug leads—A predictive structural and biodiversity-based analysis. Phytochem. Lett. 2014;10.
[31] Maha Hamad, Intesar Tarik Numan, Ali Faris Hassan. Evaluation of anti-inflammatory effect of ethyl acetate and methanol extracts of Loranthus europaeus in experimental models of acute inflammation in rats. International Journal of Pharmaceutical Sciences Review and Research. 2013; 23(2):170-17.
[32] Gandhi V., Plunkett W., Cortes J.E. Omacetaxine: A Protein Translation Inhibitor for Treatment of Chronic Myelogenous Leukemia. Clin. Cancer Res. 2014;20:1735–1740.
[33] Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature. 2009;458:719–724.
[34] Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem. 2004;73:39–85.
[35] Hassan, Ali F., Numan, Intesar T, Hamad, Maha N. Evaluation of genotoxicity and effect of petroleum ether extract of Euphorbia lathyris on bone marrow cells: In-vivo study. International Journal of Pharmaceutical Sciences Review and Research 2025; 32(2): 116 – 12).
[36] Hincks JR, Kim HY, Segall HJ, Molyneux RJ, Stermitz FR, Coulombe RA, Jr. 1991. DNA cross-linking in mammalian cells by pyrrolizidine alkaloids: structure–activity relationships. Toxicol. Appl. Pharmacol 111: 90–98.
[37] Coulombe RA Jr., Drew GL, Stermitz FR. 1999. Pyrrolizidine alkaloids crosslink DNA with actin. Toxicol. Appl. Pharmacol 154: 198–202.
[38] Coulombe RA Jr., Drew GL, Stermitz FR. 1999. Pyrrolizidine alkaloids crosslink DNA with actin. Toxicol. Appl. Pharmacol 154: 198–202.
[39] Kim HY, Stermitz FR, Coulombe RA Jr., 1995. Pyrrolizidine alkaloid-induced DNA–protein cross-links. Carcinogenesis 16: 2691–2697.
[40] Petry TW, Bowden GT, Huxtable RJ, Sipes IG. 1984. Characterization of hepatic DNA damage induced in rats by the pyrrolizidine alkaloid monocrotaline. Cancer Res. 44: 1505–1509.
[41] Tepe JJ, Williams RM. 1999. Reductive activation of a hydroxylamine hemiacetal derivative of dehydromonocrotaline: the fi rst reductively activated pyrrolizidine alkaloid capable of cross-linking DNA. Angew. Chem. Int. Ed. Engl 38: 3501–3503.
[42] Pereira TN, Webb RI, Reilly PE, Seawright AA, Prakash AS. 1998. Dehydromonocrotaline generates sequence-selective N-7 guanine alkylation and heat and alkali stable multiple fragment DNA crosslinks. Nucleic Acids Res. 26: 5441–5447.
[43] Weidner MF, Sigurdsson ST, Hopkins PB. 1990. Sequence preferences of DNA interstrand cross-linking agents: dG-to-dG cross-linking at 5’-CG by structurally simplifi ed analogues of mitomycin C. Biochemistry 29: 9225–9233.
[44] Kim HY, Stermitz FR, Li JK, Coulombe RA Jr., 1999. Comparative DNA crosslinking by activated pyrrolizidine alkaloids. Food Chem. Toxicol 37: 619–625.
[45] Hincks JR, Kim HY, Segall HJ, Molyneux RJ, Stermitz FR, Coulombe RA, Jr. 1991. DNA cross-linking in mammalian cells by pyrrolizidine alkaloids: structure–activity relationships. Toxicol. Appl. Pharmacol 111: 90–98.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Stallion Journal for Multidisciplinary Associated Research Studies
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
10.55544/sjmars
editor@sjmars.com | 
+91-8874396939
